FDA Bans Convicted Drug Importer for a Decade-Long Timeout
Published Date: 4/23/2026
Notice
Summary
Kimberly Schaff Kiehl is banned for 10 years from importing any drugs into the U.S. because she was convicted of serious crimes related to drug importation. She didn’t respond to the FDA’s notice, so the ban started on April 23, 2026. She can apply to end the ban anytime, but must follow special rules to keep her info private.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
10-Year Ban on Drug Importing
The FDA has debarred Kimberly Schaff Kiehl for 10 years from importing or offering for import any drug into the United States, effective April 23, 2026. The order follows her July 3, 2025 felony conviction and notes she received about $341,218 from sales and imported roughly 176 foreign packages between January 9, 2019 and September 19, 2021.
Prohibition on Acting With Debarred Importer
Under 21 U.S.C. 331(cc), importing or offering for import any drug 'by, with the assistance of, or at the direction of' Kimberly Schaff Kiehl is a prohibited act, effective April 23, 2026. That means third parties cannot lawfully use Ms. Kiehl to import drugs during her debarment period.
Right to Apply to End Debarment
Ms. Kiehl may apply at any time for termination of the debarment under section 306(d)(1) of the FD&C Act. The FDA provides submission instructions and notes that electronic submissions will be posted publicly, so confidential information should be submitted using the paper confidential-submission process described.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767 — Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He didn’t respond to the FDA’s warning, so the ban started on May 15, 2026. If he wants to end the ban early, he can apply anytime, but must follow special rules to keep his info private.
2026-09533 — Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information
The FDA wants your help to improve tests that spot kidney damage caused by medicines. They’re asking researchers, doctors, and companies to share data by July 13, 2026, so they can make these kidney safety markers better and faster. This could lead to safer drugs and smarter health checks, benefiting patients and the medical community alike.
2026-09508 — Azodicarbonamide (ADA); Request for Information
The FDA is asking for info about azodicarbonamide (ADA), a chemical used in some foods and food packaging, to check if it’s still safe. Food makers, scientists, and anyone with data should share what they know by July 13, 2026. This review could lead to changes in how ADA is used, affecting food companies and possibly costs down the line.
2026-09543 — Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This update affects drug makers and helps keep medicine safe by improving how side effects are tracked. You’ve got until July 13, 2026, to share your comments—no cost to join, just your voice!
2026-09544 — Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If renewed, the company can keep marketing them this way, with the comment period starting May 13, 2026.
2026-09507 — Butylated Hydroxytoluene (BHT); Request for Information
The FDA wants to know more about how butylated hydroxytoluene (BHT), a chemical used in food and food packaging, is being used and if it’s still safe. They’re asking companies, scientists, and the public to share any info by July 13, 2026. This could lead to changes in rules that affect food makers and might impact what’s allowed in your snacks and packaging.
Previous / Next Documents
Previous: 2026-07859 — Paperwork Reduction Act; Proposed Collection; Comment Request
The Office of National Drug Control Policy wants your thoughts on updating how they collect info for two programs fighting youth drug abuse. These changes affect communities using Drug-Free Communities and CARA grants, aiming to better track progress against opioid and meth use among teens. You’ve got 60 days to comment, and this update helps keep the programs sharp without adding extra paperwork or costs.
Next: 2026-07866 — Wooden Cabinet and Vanities and Components Thereof From the People's Republic of China: Final Results and Recission, in Part, of Antidumping Duty Administrative Review; 2023-2024
The U.S. Department of Commerce found that two Chinese companies, Ancientree and KM Cabinetry, sold wooden cabinets and vanities at unfairly low prices from April 2023 to March 2024. This means they’ll face extra duties to level the playing field for U.S. businesses. These changes take effect April 23, 2026, and could impact import costs and prices.